WPL – Buy
WPL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.
Watch Last Night’s Webinar
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Coles – Buy
Coles Group is under Algo Engine buy conditions.
Investors should watch the short-term momentum indicators for a turn higher within the highlighted range.
CSL – Algo Buy
CSL:ASX is under Algo Engine buy conditions.
1H21 NPAT of US$1.8bn. FY21 guidance retained at US$2.2bn, which implies a weaker 2H21. We expect to see earnings upgraded prior to the completion of the 2H.
CSL trades on a forward yield of 1%.
Amcor – Algo Buy
Amcor is under Algo Engine buy conditions. We expect buying support to hold above $15.00.
Investors may consider selling out-of-the-money call options to enhance the income.
Transurban – Algo Buy
TCL:ASX is under Algo Engine buy conditions and has now rallied over 10% from our highlighted entry level.
We continue to see TCL as an attractive opportunity within the infrastructure space.
TCL goes ex-div $0.165 on 29 June.
Cure ETF – Buy
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
.
Nextdc 412% Gain
Our Algo Model has now closed out one of the best performing investments. After holding Nextdc for 2054 days, the realised gain was 412.93%.
IAG – Recovery Play
We add IAG to our “high risk” recovery basket, which also includes CIM & A2M.
We expect IAG to see improved earnings into FY22 & FY23. It’s likely we’re nearing the inflection point, where investors begin pricing in the anticipated recovery.
Buy IAG with stops below $4.60
Ampol – Technical Review
Ampol has reported its financials for the 12 months ending 31 December 2020, with full year earnings of $401 million. Earnings were down from $607 million in the year prior.
1Q21 EBIT was A$150mn, but included an A$18mn FX gain.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453